Strategy to Enhance the Therapeutic Effect of Doxorubicin in Human Hepatocellular Carcinoma by Selenocystine, a Synergistic Agent That Regulates the ROS-mediated Signaling
Oncotarget - United States
doi 10.18632/oncotarget.1854
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 15, 2014
Authors
Publisher
Impact Journals, LLC